Starting ART reduces TB risk for HIV-positive patients in South Africa
Presumptive treatment of TB in advanced HIV no better than giving ART and isoniazid
Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows
XDR-TB in South Africa is largely spread person-to-person, not by failure of drug treatment
